{"entity":{"type":"insider","cik":"0001322927","url":"/insider/0001322927","json_url":"/insider/0001322927.json","name":"Ahrens Brenton Karl","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":9,"first":"2011-06-02","last":"2022-09-20","span_basis":"filed_date"},"name_variants":[{"name":"Ahrens Brenton Karl","source":"filing","n_filings":9,"first_seen":"2011-06-02","last_seen":"2022-09-20"}],"transactions":[{"id":6201035,"accession":"0000899243-22-031603","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-031603","line_url":"/filing/0000899243-22-031603#line-3","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7246.0,"shares_display":"7,246","price_per_share":1.7817,"price_display":"1.78","price_state":"stated","total_value":12910.1982,"total_display":"12,910.20","total_whole":"12,910","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2022-09-20","scope":"insider"},{"id":6201030,"accession":"0000899243-22-031603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031603","line_url":"/filing/0000899243-22-031603#line-2","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":1.7652,"price_display":"1.77","price_state":"stated","total_value":26478.0,"total_display":"26,478.00","total_whole":"26,478","shares_owned_after":7246.0,"shares_owned_after_display":"7,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-20","scope":"insider"},{"id":6201024,"accession":"0000899243-22-031603","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031603","line_url":"/filing/0000899243-22-031603#line-1","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":1.9028,"price_display":"1.90","price_state":"stated","total_value":28542.0,"total_display":"28,542.00","total_whole":"28,542","shares_owned_after":22246.0,"shares_owned_after_display":"22,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6945188,"accession":"0000899243-22-031172","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-031172","line_url":"/filing/0000899243-22-031172#line-3","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":2.0181,"price_display":"2.02","price_state":"stated","total_value":30271.5,"total_display":"30,271.50","total_whole":"30,272","shares_owned_after":37246.0,"shares_owned_after_display":"37,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-15","scope":"insider"},{"id":6945184,"accession":"0000899243-22-031172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031172","line_url":"/filing/0000899243-22-031172#line-2","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":2.0971,"price_display":"2.10","price_state":"stated","total_value":31456.5,"total_display":"31,456.50","total_whole":"31,457","shares_owned_after":52246.0,"shares_owned_after_display":"52,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-15","scope":"insider"},{"id":6945182,"accession":"0000899243-22-031172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031172","line_url":"/filing/0000899243-22-031172#line-1","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":2.1412,"price_display":"2.14","price_state":"stated","total_value":32118.0,"total_display":"32,118.00","total_whole":"32,118","shares_owned_after":67246.0,"shares_owned_after_display":"67,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-15","scope":"insider"},{"id":6364875,"accession":"0000899243-22-030853","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-030853","line_url":"/filing/0000899243-22-030853#line-3","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":2.3072,"price_display":"2.31","price_state":"stated","total_value":34608.0,"total_display":"34,608.00","total_whole":"34,608","shares_owned_after":82246.0,"shares_owned_after_display":"82,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-12","scope":"insider"},{"id":6364874,"accession":"0000899243-22-030853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030853","line_url":"/filing/0000899243-22-030853#line-2","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":2.3153,"price_display":"2.32","price_state":"stated","total_value":34729.5,"total_display":"34,729.50","total_whole":"34,730","shares_owned_after":97246.0,"shares_owned_after_display":"97,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-09","filed_date":"2022-09-12","scope":"insider"},{"id":6364873,"accession":"0000899243-22-030853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-030853","line_url":"/filing/0000899243-22-030853#line-1","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3298.0,"shares_display":"3,298","price_per_share":2.2635,"price_display":"2.26","price_state":"stated","total_value":7465.023,"total_display":"7,465.02","total_whole":"7,465","shares_owned_after":112246.0,"shares_owned_after_display":"112,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"},{"id":6802071,"accession":"0001209191-18-034204","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-034204","line_url":"/filing/0001209191-18-034204#line-4","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":506656.0,"shares_display":"506,656","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":6586528.0,"total_display":"6,586,528.00","total_whole":"6,586,528","shares_owned_after":1733170.0,"shares_owned_after_display":"1,733,170","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"},{"id":2465896,"accession":"0001209191-12-039207","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-039207","line_url":"/filing/0001209191-12-039207#line-2","is_derivative":false,"issuer_cik":"0001322927","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001322927","owner_cik":"0001322927","owner_name":"Ahrens Brenton Karl","owner_display_name":"Ahrens Brenton Karl","owner_url":"/insider/0001322927","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555555.0,"shares_display":"555,555","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":1902030.0,"shares_owned_after_display":"1,902,030","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2012-07-26","scope":"insider"},{"id":2958869,"accession":"0001181431-12-014749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-014749","line_url":"/filing/0001181431-12-014749#line-2","is_derivative":false,"issuer_cik":"0001012837","issuer_name":"ACTIVE NETWORK INC","issuer_ticker":"ACTV","issuer_name_source":null,"issuer_url":"/issuer/0001012837","owner_cik":null,"owner_name":"Ahrens Brenton Karl; Ibrahim Maha Saleh; Bloch Stephen M; GREEN L STEPHEN; Hutton Wende S","owner_display_name":"Ahrens Brenton Karl","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48000.0,"shares_display":"48,000","price_per_share":16.0008,"price_display":"16.00","price_state":"stated","total_value":768038.4,"total_display":"768,038.40","total_whole":"768,038","shares_owned_after":5088299.0,"shares_owned_after_display":"5,088,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-05","filed_date":"2012-03-06","scope":"insider"},{"id":2958855,"accession":"0001181431-12-014749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-014749","line_url":"/filing/0001181431-12-014749#line-1","is_derivative":false,"issuer_cik":"0001012837","issuer_name":"ACTIVE NETWORK INC","issuer_ticker":"ACTV","issuer_name_source":null,"issuer_url":"/issuer/0001012837","owner_cik":null,"owner_name":"Ahrens Brenton Karl; Ibrahim Maha Saleh; Bloch Stephen M; GREEN L STEPHEN; Hutton Wende S","owner_display_name":"Ahrens Brenton Karl","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146486.0,"shares_display":"146,486","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2343776.0,"total_display":"2,343,776.00","total_whole":"2,343,776","shares_owned_after":5136299.0,"shares_owned_after_display":"5,136,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-02","filed_date":"2012-03-06","scope":"insider"},{"id":2149479,"accession":"0001181431-12-013900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-013900","line_url":"/filing/0001181431-12-013900#line-2","is_derivative":false,"issuer_cik":"0001012837","issuer_name":"ACTIVE NETWORK INC","issuer_ticker":"ACTV","issuer_name_source":null,"issuer_url":"/issuer/0001012837","owner_cik":null,"owner_name":"Hutton Wende S; Bloch Stephen M; GREEN L STEPHEN; Ibrahim Maha Saleh; Ahrens Brenton Karl","owner_display_name":"Hutton Wende S","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92200.0,"shares_display":"92,200","price_per_share":16.0004,"price_display":"16.00","price_state":"stated","total_value":1475236.88,"total_display":"1,475,236.88","total_whole":"1,475,237","shares_owned_after":5282785.0,"shares_owned_after_display":"5,282,785","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-02","scope":"insider"},{"id":2149475,"accession":"0001181431-12-013900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-013900","line_url":"/filing/0001181431-12-013900#line-1","is_derivative":false,"issuer_cik":"0001012837","issuer_name":"ACTIVE NETWORK INC","issuer_ticker":"ACTV","issuer_name_source":null,"issuer_url":"/issuer/0001012837","owner_cik":null,"owner_name":"Hutton Wende S; Bloch Stephen M; GREEN L STEPHEN; Ibrahim Maha Saleh; Ahrens Brenton Karl","owner_display_name":"Hutton Wende S","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45986.0,"shares_display":"45,986","price_per_share":16.0046,"price_display":"16.00","price_state":"stated","total_value":735987.5356,"total_display":"735,987.54","total_whole":"735,988","shares_owned_after":5374985.0,"shares_owned_after_display":"5,374,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-29","filed_date":"2012-03-02","scope":"insider"},{"id":3051428,"accession":"0001181431-12-013013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-013013","line_url":"/filing/0001181431-12-013013#line-2","is_derivative":false,"issuer_cik":"0001012837","issuer_name":"ACTIVE NETWORK INC","issuer_ticker":"ACTV","issuer_name_source":null,"issuer_url":"/issuer/0001012837","owner_cik":null,"owner_name":"Bloch Stephen M; Ahrens Brenton Karl; Hutton Wende S; Ibrahim Maha Saleh; GREEN L STEPHEN","owner_display_name":"Bloch Stephen M","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62300.0,"shares_display":"62,300","price_per_share":16.0017,"price_display":"16.00","price_state":"stated","total_value":996905.91,"total_display":"996,905.91","total_whole":"996,906","shares_owned_after":5420971.0,"shares_owned_after_display":"5,420,971","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-28","filed_date":"2012-02-29","scope":"insider"},{"id":3051424,"accession":"0001181431-12-013013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-013013","line_url":"/filing/0001181431-12-013013#line-1","is_derivative":false,"issuer_cik":"0001012837","issuer_name":"ACTIVE NETWORK INC","issuer_ticker":"ACTV","issuer_name_source":null,"issuer_url":"/issuer/0001012837","owner_cik":null,"owner_name":"Bloch Stephen M; Ahrens Brenton Karl; Hutton Wende S; Ibrahim Maha Saleh; GREEN L STEPHEN","owner_display_name":"Bloch Stephen M","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78400.0,"shares_display":"78,400","price_per_share":15.8511,"price_display":"15.85","price_state":"stated","total_value":1242726.24,"total_display":"1,242,726.24","total_whole":"1,242,726","shares_owned_after":5483271.0,"shares_owned_after_display":"5,483,271","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-27","filed_date":"2012-02-29","scope":"insider"},{"id":8843099,"accession":"0001181431-11-034465","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-034465","line_url":"/filing/0001181431-11-034465#line-3","is_derivative":false,"issuer_cik":"0001012837","issuer_name":"ACTIVE NETWORK INC","issuer_ticker":"ACTV","issuer_name_source":null,"issuer_url":"/issuer/0001012837","owner_cik":null,"owner_name":"Ahrens Brenton Karl; Hutton Wende S; Bloch Stephen M; Ibrahim Maha Saleh; GREEN L STEPHEN","owner_display_name":"Ahrens Brenton Karl","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1371701.0,"shares_display":"1,371,701","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":20575515.0,"total_display":"20,575,515.00","total_whole":"20,575,515","shares_owned_after":5561671.0,"shares_owned_after_display":"5,561,671","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-05-31","filed_date":"2011-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Director","n_filings":4,"first_seen":"2018-05-30","last_seen":"2022-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2012-07-26","last_seen":"2012-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001163932","name":"ACTIVE NETWORK INC","url":"/issuer/0001163932","role":"Ten percent owner","n_filings":4,"first_seen":"2011-06-02","last_seen":"2012-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001322927","retrieved_at":"2026-08-25T04:06:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}